Cargando…
Comparison of total and neutralizing SARS-CoV-2 spike antibodies against omicron and other variants in paired samples after two or three doses of mRNA vaccine
Recognizing that anti-SARS-CoV-2 antibody levels wane over time following the 2-dose SARS-CoV-2 mRNA series, the FDA approved a booster dose for people greater than 12 years old. Limited data exist on whether a booster dose of the mRNA vaccine results in greater antibody protection than the primary...
Autores principales: | Debes, Amanda K., Xiao, Shaoming, Egbert, Emily R., Caturegli, Patrizio, Sitaras, Ioannis, Pekosz, Andrew, Milstone, Aaron M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820679/ https://www.ncbi.nlm.nih.gov/pubmed/35132427 http://dx.doi.org/10.1101/2022.01.26.22269819 |
Ejemplares similares
-
Neutralizing SARS-CoV-2 Spike Antibodies against Omicron in Paired Samples after Two or Three Doses of mRNA Vaccine
por: Debes, Amanda K., et al.
Publicado: (2022) -
Durability of Spike Immunoglobin G Antibodies to SARS-CoV-2 Among Health Care Workers With Prior Infection
por: Egbert, Emily R., et al.
Publicado: (2021) -
Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers
por: Debes, Amanda K., et al.
Publicado: (2021) -
Post-Vaccination Neutralization Responses to Omicron Sub-Variants
por: Jacobsen, Henning, et al.
Publicado: (2022) -
Structures of Omicron spike complexes and implications for neutralizing antibody development
por: Guo, Hangtian, et al.
Publicado: (2022)